1. Home
  2. CLRB vs GIGM Comparison

CLRB vs GIGM Comparison

Compare CLRB & GIGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLRB
  • GIGM
  • Stock Information
  • Founded
  • CLRB 2002
  • GIGM 1998
  • Country
  • CLRB United States
  • GIGM Taiwan
  • Employees
  • CLRB N/A
  • GIGM N/A
  • Industry
  • CLRB Biotechnology: Pharmaceutical Preparations
  • GIGM Computer Software: Programming Data Processing
  • Sector
  • CLRB Health Care
  • GIGM Technology
  • Exchange
  • CLRB Nasdaq
  • GIGM Nasdaq
  • Market Cap
  • CLRB 17.6M
  • GIGM 17.9M
  • IPO Year
  • CLRB N/A
  • GIGM 2000
  • Fundamental
  • Price
  • CLRB $4.98
  • GIGM $1.39
  • Analyst Decision
  • CLRB Hold
  • GIGM
  • Analyst Count
  • CLRB 2
  • GIGM 0
  • Target Price
  • CLRB N/A
  • GIGM N/A
  • AVG Volume (30 Days)
  • CLRB 1.3M
  • GIGM 29.6K
  • Earning Date
  • CLRB 08-12-2025
  • GIGM 07-30-2025
  • Dividend Yield
  • CLRB N/A
  • GIGM N/A
  • EPS Growth
  • CLRB N/A
  • GIGM N/A
  • EPS
  • CLRB N/A
  • GIGM N/A
  • Revenue
  • CLRB N/A
  • GIGM $3,103,000.00
  • Revenue This Year
  • CLRB N/A
  • GIGM N/A
  • Revenue Next Year
  • CLRB N/A
  • GIGM N/A
  • P/E Ratio
  • CLRB N/A
  • GIGM N/A
  • Revenue Growth
  • CLRB N/A
  • GIGM N/A
  • 52 Week Low
  • CLRB $4.36
  • GIGM $1.26
  • 52 Week High
  • CLRB $94.50
  • GIGM $1.80
  • Technical
  • Relative Strength Index (RSI)
  • CLRB 33.34
  • GIGM 43.40
  • Support Level
  • CLRB $6.50
  • GIGM $1.41
  • Resistance Level
  • CLRB $8.30
  • GIGM $1.45
  • Average True Range (ATR)
  • CLRB 1.42
  • GIGM 0.05
  • MACD
  • CLRB -0.66
  • GIGM -0.00
  • Stochastic Oscillator
  • CLRB 1.63
  • GIGM 9.62

About CLRB Cellectar Biosciences Inc.

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.

About GIGM GigaMedia Limited

GigaMedia Ltd is a publisher of online games. It has only one reportable segment, Digital Entertainment service. Digital Entertainment service business operates a portfolio of online games, mainly targeting online game players across Europe, and Asia, including Greater China and Southeast Asia. The company's portfolio of online games includes predominantly PC-based, non-cash gambling, or casino casual games, including MahJong and various card and table games. The company's product lines include MahJong, AkaSeka, Yume 100, Fun Vegas, and others. The company operates in Taiwan and Hong Kong.

Share on Social Networks: